A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and Neolpharma

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 26, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions

Healthy Participants

Interventions

DRUG

Spironolactone/Hydrochlorothiazide (25 mg/25 mg) film coated tablets from Viatris

Manufactured at Viatris

DRUG

Spironolactone/Hydrochlorothiazide (25 mg/25 mg) film coated tablets from Neolpharma.

Manufactured at Neolpharma.

Trial Locations (1)

Clinical Trials of Texas, LLC, San Antonio